Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Pfizer
Jonsson Comprehensive Cancer Center
Pfizer
M.D. Anderson Cancer Center
Ikena Oncology
Jonsson Comprehensive Cancer Center
Eli Lilly and Company
Columbia University
ABM Therapeutics Corporation
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Celgene
SWOG Cancer Research Network
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
Case Comprehensive Cancer Center